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GMP
QC HPLC VALIDATION
EudraLex - Volume 4 GMP Guidelines
Good Manufacturing Practice is that part of Quality Management which ensures that products are
consistently produced and controlled to the quality standards appropriate to their intended use and as
required by the Marketing Authorisation, Clinical Trial Authorisation or product specification.
Good Manufacturing Practice is concerned with both production and quality control.
EudraLex - Volume 4 GMP Guidelines
Quality Control is that part of Good Manufacturing Practice
which is concerned with sampling, specifications and testing, and
with the organisation, documentation and release procedures
which ensure that the necessary and relevant tests are actually
carried out and that materials are not released for use, nor
products released for sale or supply, until their quality has been
judged to be satisfactory.
ISO/IEC 17025:2005 5.4.5
Validation is the confirmation by
examination and the provision of
objective evidences that the particular























• ISO/IEC 17025 General requirements for the competence of testing 
and calibration laboratories
• ISO 5725 Accuracy (trueness and precision) of measurement 
methods and results
• ICH Q2 Validation of Analytical procedures
Q2A: terminology ; Q2B: methodology
• Directive 96/23/CE and decision 2002/657/CE
• EDQM Technical Guide for the elaboration of monographs, 2011
• STP PHARMA PRATIQUES, 13, 3, 2003 Validation of quantitative 





• Accuracy    = trueness + precision




• Limit of detection (LOD) and Limit of quantification (LOQ)
• Assay range
• Linearity (results vs conct.)  <> response function (signal vs conct.)












Specificity YES YES YES YES
Accuracy YES YES
Repeatability YES YES
Intermediate precision YES YES
Limit of Detection LOD YES YES
Limit of Quantification LOQ YES
Linearity YES YES
Assay Range YES YES
Identification
3 important rules for the validation of 
analytical methods
• Validation covers all operations of the methods from sampling 
(volume or weight) to generation of results (including 
mathematical transformations of data).
• Validation covers a finite range of concentration: extrapolation 
outside the range is not allowed.
• Validation is matrix specific. A new validation must be performed 
for each new matrix. 
11/05/2015
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Validation of Eur. Pharm. methods ?
• The pharmacopoeial methods given in monographs and general
chapters have been validated in accordance with accepted
scientific practice and current recommendations on analytical
validation. Unless otherwise stated in the monograph or general
chapter, validation of the test methods by the analyst is not
required.
• When implementing a pharmacopoeial method, the user must
assess whether and to what extent the suitability of the method
under the actual conditions of use needs to be demonstrated
according to relevant monographs, general chapters and quality
systems.
Accuracy profile as decision tool
STP PHARMA PRATIQUES, 13, 3, 2003 Validation of quantitative analytical procedure, 






19F-FDG limit test in 18F-FDG 
• FLUDEOXYGLUCOSE (18F) INJECTION, European Pharmacopeia 8, 
01/2014:1325:    MAX:   0.5 mg/V     V= maximum injected volume
• Liquid chromatography
- Dionex ICS3000 with autosampler
- Detection: amperometry (30°C) 
- Colonne Dionex Carbopac PA10 (25°C)
- 1mL/min  100mM NaOH
- Conditionnement: 1M NaOH every 3 injections







Specificity YES YES YES YES
Accuracy YES YES
Repeatability YES YES
Intermediate precision YES YES
Limit of Detection LOD YES YES
Limit of Quantification LOQ YES
Linearity YES YES













FDM / FDG  =  1.5
Calculated:  1.6







Specificity YES YES YES YES
Accuracy YES YES
Repeatability YES YES
Intermediate precision YES YES
Limit of Detection LOD YES YES
Limit of Quantification LOQ YES
Linearity YES YES




PHASE 1 : organization  
• Description of the analytical method
• Information on product to assay and analytical system (HPLC, GC…)
• Protocols for samples preparation
• CS: calibration samples = solution of product in a suitable solvent
• VS: validation samples = solution of product in the real matrix
• Concentration levels for CS et VS
• Validation plan.    Ex. 3 days/1op    or   2 days/2op
• Criteria to be evaluated
PHASE 2 : preparation of CS
Bulk 1       dilutions 1
Bulk 2       dilution 2









PHASE 3 : preparation of VS











Results of injections of series
Relationship between the introduced  and the 
back-calculated amounts
Linear Regression Through 0 fitted with the
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